Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zinc glycinate is a chelated form of the essential mineral zinc in which each ion of zinc is bound to two molecules of the amino acid glycine. This chelation enhances its absorption and bioavailability compared to other forms such as zinc oxide or gluconate[6][7]. Zinc plays critical roles in catalytic activity for hundreds of enzymes and supports immune function, protein metabolism, antioxidant activity, reproductive health, sensory perception (taste), neurological function and cellular growth[4][6][7]. As a supplement or ingredient in medical foods (such as combinations with bioflavonoids), it may be used for dietary management of osteoarthritis symptoms like swelling and joint discomfort[1], as well as general support for immune health and wound healing[6]. It is also found in multi-ingredient products targeting bone health or combined with other minerals/vitamins[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zinc glycinate.